Eyevensys Receives Approval from the UK Medicines and Healthcare products Regulatory Agency to advance its EyeCET platform into clinical development
https://www.eyevensys.com/wp-content/uploads/2020/02/scott-webb-XtmzWUyJf0E-unsplash-1.jpg
2500
1668
Eyevensys
https://www.eyevensys.com/wp-content/uploads/2020/02/scott-webb-XtmzWUyJf0E-unsplash-1.jpg
Eyevensys Receives Approval from the UK Medicines and Healthcare products Regulatory Agency to advance its EyeCET platform into clinical development
Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of therapeutic proteins in the eye to…